Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities, Ltd. et al
| Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc. |
| Eugia Pharma Specialities, Ltd., Aurobindo Pharma Ltd. and Aurobindo Pharma U.S.A., Inc. |
| 1:2022cv01611 |
| December 20, 2022 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 13, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 14
SO ORDERED, re (13 in 1:22-cv-01611-CFC, 16 in 1:22-cv-01480-CFC) STIPULATION TO EXTEND TIME proposed scheduling order to February 27, 2023, filed by Natco Pharma Ltd., Natco Pharma, Inc. Resetting Deadlines: Notice of Compliance deadline set for 2/27/2023. Signed by Judge Colm F. Connolly on 2/13/2023. Associated Cases: 1:22-cv-01480-CFC, 1:22-cv-01611-CFC(kmd)
|
| Filing 13 STIPULATION TO EXTEND TIME proposed scheduling order to February 27, 2023 - filed by Natco Pharma Ltd., Natco Pharma, Inc.. (Cragg, Tyler) |
| Filing 12 ANSWER to #9 Answer to Complaint, Counterclaim by Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd..(Balick, Steven) |
|
Filing 11
ORDER, having been assigned these cases which are listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before February 13, 2023, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 2/13/2023.) Signed by Judge Colm F. Connolly on 1/12/2023. Associated Cases: 1:22-cv-01480-CFC, 1:22-cv-01611-CFC, 1:23-cv-00008-CFC(nmf)
|
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited, Corporate Parent Mviyes Pharma Ventures Private Limited for Eugia Pharma Specialities, Ltd.; Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma U.S.A., Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialities, Ltd.. (Dorsney, Kenneth) |
| Filing 9 ANSWER to #1 Complaint, , COUNTERCLAIM against All Plaintiffs by Aurobindo Pharma Ltd., Eugia Pharma Specialities, Ltd., Aurobindo Pharma U.S.A., Inc..(Dorsney, Kenneth) |
| Filing 8 SUMMONS Returned Executed by Taiho Pharmaceutical Co., Ltd., Taiho Oncology, Inc..Aurobindo Pharma U.S.A., Inc. served on 12/29/2022, answer due 1/19/2023. (Balick, Steven) |
| Filing 7 STANDING ORDER REGARDING BRIEFING IN ALL CASES. Associated Cases: 1:22-cv-01611-CFC et al.(kmd) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd., Corporate Parent Taiho Pharmaceutical Co., Ltd. for Taiho Oncology, Inc. filed by Taiho Oncology, Inc.. (srs) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Taiho Pharmaceutical Co., Ltd. filed by Taiho Pharmaceutical Co., Ltd.. (srs) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,456,399 B2 ;10,960,004 B2. (srs) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 17, 2022. Date of Expiration of '399 Patent: February 3, 2037. Expiration of '004 Patent: February 3, 2037.Thirty Month Stay Deadline: 3/23/2023. (srs) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Filing 1 COMPLAINT filed against Aurobindo Pharma Ltd., Aurobindo Pharma U.S.A., Inc., and Eugia Pharma Specialities, Ltd. ( Filing fee $ 402, receipt number ADEDC-4029137.) - filed by Taiho Pharmaceutical Co., Ltd., Taiho Oncology, Inc. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(srs) |
| No Summons Issued. (srs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
